Orion Engineered Carbons S.A. — Q1 2020 Form 10-Q
Business context and period. Orion manufactures carbon black for tire and rubber applications (Rubber) and for coatings, polymers, printing and other uses (Specialties). This unaudited report covers the three months ended March 31, 2020, compared with Q1 2019. The company reported that COVID-19-related demand declines became pronounced in mid-March, particularly as tire and auto plants closed.
Key financial results
| Metric | Q1 2020 | Q1 2019 |
|---|---|---|
| Net sales | $336.0 million | $384.7 million |
| Gross profit | $90.2 million | $98.0 million |
| Income from operations | $37.5 million | $34.7 million |
| Net income | $18.0 million | $19.0 million |
| Diluted earnings per share | $0.29 | $0.31 |
| Adjusted EBITDA, non-GAAP | $63.8 million | $64.6 million |
| Operating cash flow | $4.9 million | $26.2 million |
| Capital expenditures | $50.9 million | $22.5 million |
Gross margin was approximately 26.8%, compared with 25.5%. Contribution margin, a company-defined non-GAAP measure, was $131.9 million versus $136.3 million; contribution margin per metric ton rose to $560.8 from $518.7. Dividends of $0.20 per share were paid in both periods.
At March 31, cash and cash equivalents were $107.5 million (plus $2.7 million of restricted cash). Current assets were $569.7 million and current liabilities $373.7 million. Reported current and long-term debt and other financial liabilities totaled $764.7 million, including $138.3 million of local short-term borrowings and ancillary facilities. Term loans mature July 2024; the €250 million revolving credit facility matures April 2024. The filing reports $138.3 million drawn through the RCF or related ancillary facilities, against a stated RCF capacity of approximately $273.9 million.
Changes versus Q1 2019
- Sales fell 12.7%; volume declined 10.5%, from 262.8 thousand to 235.1 thousand metric tons. Lower feedstock costs passed through to customers and unfavorable foreign-exchange translation also reduced revenue; price increases and product mix partly offset these effects.
- Operating income increased 8.2%, as lower SG&A—primarily lower personnel, bonus and incentive-plan costs—more than offset lower gross profit. Net income declined, with higher net financial expense and a $2.4 million pension actuarial-loss reclassification among the factors.
- Adjusted EBITDA decreased 1.1%. Specialty Adjusted EBITDA was $28.1 million versus $29.4 million; Rubber was $35.8 million versus $35.2 million. Segment Adjusted EBITDA margins improved to 23.4% from 22.3% for Specialty and to 16.5% from 13.9% for Rubber.
- Operating cash flow fell to $4.9 million, mainly reflecting working-capital outflows. Investing outflows rose with environmental and maintenance spending. Financing cash inflows included $109.8 million from current financial liabilities/local borrowing, which supported liquidity amid COVID-19 uncertainty.
Outlook, risks and unusual items
- Outlook: No quantified earnings or revenue guidance is provided. Management stated it expected cash on hand, operating cash flows and borrowings to cover operating expenses, debt service and capital expenditures for the foreseeable future, while continuing to monitor working capital and spending. The filing emphasizes substantial uncertainty around COVID-19’s duration and impact.
- COVID-19: The company cited reduced demand, supply-chain and operating disruption, facility closures, potential customer payment delays/defaults, and economic recession risk. It reported a sharp tire-volume decline in the final two weeks of the quarter. Future impacts were described as uncertain and potentially material.
- EPA consent decree: Pollution-control and monitoring installations at four U.S. plants are estimated to require total capital expenditures of approximately $230–$270 million; about $85 million had been spent to date. Q1 spending was $22.7 million. COVID-related construction delays led Orion to declare force majeure and request timeline extensions. Costs, timing and compliance outcomes remain uncertain.
- Evonik indemnity dispute: Orion initiated arbitration in June 2019 seeking recovery of certain EPA-related costs. Evonik is not honoring Orion’s claims, and the company cautioned that recovery is not assured; it expects substantial costs to exceed the indemnity’s scope by tens of millions of dollars. Evonik counterclaims were described as not material by Orion.
- Other notable items: Inventory reserves increased by $3.4 million in the quarter, including a $2.9 million net-realizable-value adjustment. Stock-based compensation expense was a $1.1 million credit, partly from reversals because performance targets were no longer expected to be met. Foreign-currency translation produced a $24.1 million loss in other comprehensive income. Long-term raw-material purchase commitments were $133.3 million; reported pension obligations were $69.5 million.
Important facts for investors to verify
- Whether COVID-19 demand, customer payment and supply-chain impacts worsen after quarter-end, and how they affect liquidity and operating cash flow.
- Available borrowing capacity and terms of local facilities, given the quarter’s increased short-term borrowing and low operating cash generation.
- Final EPA project scope, total cost, schedule extensions and any recovery under the Evonik indemnity or outcome of arbitration.
- Whether working-capital levels, inventory valuation and raw-material price movements create further cash needs or charges.
- Whether dividends remain sustainable; the filing gives no assurance of future dividends at historical levels.